Cytokinetics, Incorporated earnings per share and revenue

CYTK earnings per share for the last quarter are -1.26 USD whereas the estimation was -1.19 USD which accounts for -5.61% surprise. Company revenue for the same period amounts to 16.93 M USD despite the estimated figure of 1.75 M USD. Estimated earnings per share for the next quarter are -1.36 USD, and revenue is expected to reach 3.80 M USD. Also watch annual changes over time to get a bigger picture of CYTK earnings per share and revenue dynamics.